4BIO Capital is a unique team of passionate academics, physician-scientists, industry executives and investment professionals that have come together to address the challenge of chronic disease through early-stage investment in advanced therapies

With in-depth understanding being the key to success in the rapidly developing therapeutic landscape, 4BIO only invests in advanced therapies, offering investors undiluted access to the fastest growing field of medicine

The team have not only backed successful advanced therapy companies, but have also contributed to the scientific progress of the field through their own bench research

4BIO scientific advisory board includes founders of gene therapy field in academic and hospital settings, leading groups in world centres of academic and clinical excellence